Rolf Huerta

23andMe ft. Anne Wojcicki - How a DNA startup took on the FDA and redefined health tech

Anne Wojcicki, Richard Scheller, Rolf Huerta

Founded by Anne Wojcicki to democratize genetic access, 23andMe rapidly expanded to over 14 million users before navigating a critical 2013 FDA mandate that forced a multi-year transition from an unregulated startup to a compliant healthcare entity. Following a 2019 market stall, the company acquired Lemonade Health to launch a full-stack consumer model while simultaneously leveraging its vast data to pivot into high-risk therapeutics, recently advancing its first investigational cancer antibody into Phase II trials. This strategic evolution transforms the organization from a direct-to-consumer ancestry provider into a leader in genomic-based drug discovery and personalized preventive care.